S&P 500   4,282.37
DOW   33,762.76
QQQ   354.65
MarketBeat Week in Review – 5/29 - 6/2
How A.I. Could Make Most 21st Century Diseases EXTINCT (Ad)
Biden signs debt ceiling bill that pulls US back from brink of unprecedented default
Russia bans 'unfriendly' countries' journalists from showpiece economic gathering
How A.I. Could Make Most 21st Century Diseases EXTINCT (Ad)
Slow start to New York's legal pot market leaves farmers holding the bag
Oil tanker breaks down in Egypt's Suez Canal, disrupting traffic in the global waterway
How A.I. Could Make Most 21st Century Diseases EXTINCT (Ad)
With oil prices slumping, OPEC+ producers weigh more production cuts
Las Vegas ballpark pitch revives debate over public funding for sports stadiums
S&P 500   4,282.37
DOW   33,762.76
QQQ   354.65
MarketBeat Week in Review – 5/29 - 6/2
How A.I. Could Make Most 21st Century Diseases EXTINCT (Ad)
Biden signs debt ceiling bill that pulls US back from brink of unprecedented default
Russia bans 'unfriendly' countries' journalists from showpiece economic gathering
How A.I. Could Make Most 21st Century Diseases EXTINCT (Ad)
Slow start to New York's legal pot market leaves farmers holding the bag
Oil tanker breaks down in Egypt's Suez Canal, disrupting traffic in the global waterway
How A.I. Could Make Most 21st Century Diseases EXTINCT (Ad)
With oil prices slumping, OPEC+ producers weigh more production cuts
Las Vegas ballpark pitch revives debate over public funding for sports stadiums
S&P 500   4,282.37
DOW   33,762.76
QQQ   354.65
MarketBeat Week in Review – 5/29 - 6/2
How A.I. Could Make Most 21st Century Diseases EXTINCT (Ad)
Biden signs debt ceiling bill that pulls US back from brink of unprecedented default
Russia bans 'unfriendly' countries' journalists from showpiece economic gathering
How A.I. Could Make Most 21st Century Diseases EXTINCT (Ad)
Slow start to New York's legal pot market leaves farmers holding the bag
Oil tanker breaks down in Egypt's Suez Canal, disrupting traffic in the global waterway
How A.I. Could Make Most 21st Century Diseases EXTINCT (Ad)
With oil prices slumping, OPEC+ producers weigh more production cuts
Las Vegas ballpark pitch revives debate over public funding for sports stadiums
S&P 500   4,282.37
DOW   33,762.76
QQQ   354.65
MarketBeat Week in Review – 5/29 - 6/2
How A.I. Could Make Most 21st Century Diseases EXTINCT (Ad)
Biden signs debt ceiling bill that pulls US back from brink of unprecedented default
Russia bans 'unfriendly' countries' journalists from showpiece economic gathering
How A.I. Could Make Most 21st Century Diseases EXTINCT (Ad)
Slow start to New York's legal pot market leaves farmers holding the bag
Oil tanker breaks down in Egypt's Suez Canal, disrupting traffic in the global waterway
How A.I. Could Make Most 21st Century Diseases EXTINCT (Ad)
With oil prices slumping, OPEC+ producers weigh more production cuts
Las Vegas ballpark pitch revives debate over public funding for sports stadiums
NASDAQ:DKDCA

Data Knights Acquisition (DKDCA) Stock Forecast, Price & News

$10.80
0.00 (0.00%)
(As of 06/2/2023 ET)
Compare
Today's Range
$10.80
$10.80
50-Day Range
$10.66
$10.96
52-Week Range
$10.22
$10.98
Volume
21 shs
Average Volume
9,820 shs
Market Capitalization
$81.76 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A

DKDCA stock logo

About Data Knights Acquisition (NASDAQ:DKDCA) Stock

Data Knights Acquisition Corp. does not have significant operations. It intends to effect a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses in the data centers and internet technology sectors. The company was incorporated in 2021 and is based in Chessington, the United Kingdom.

Receive DKDCA Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Data Knights Acquisition and its competitors with MarketBeat's FREE daily newsletter.

DKDCA Stock News Headlines

The single greatest medical breakthrough of all time?
We are on the cusp of a medical breakthrough. And soon, this single breakthrough could lead to the cure of over 6,000 genetic diseases, including Alzheimer's, heart disease, and even cancer! This reminds me of Amgen, where early investors made as much as 46,751% when they released their revolutionary drug to the market.
Reviewing Data Knights Acquisition (DKDCA) & Its Rivals
“One-Stock Millionaire” IGNORES 99.9% of the Market
During the 2008 financial crisis, millionaire trader Jeff Clark stunned the world when he managed to double his readers’ money 26 TIMES… CNBC caught wind of this and asked Jeff to come on live TV to explain his secret.
Contrasting Data Knights Acquisition (DKDCA) and Its Rivals
Analyzing Data Knights Acquisition (DKDCA) & The Competition
Analyzing Data Knights Acquisition (DKDCA) & Its Peers
Analyzing Data Knights Acquisition (DKDCA) & Its Competitors
See More Headlines

DKDCA Price History

DKDCA Company Calendar

Today
6/03/2023
Next Earnings (Estimated)
8/21/2023
Fiscal Year End
12/31/2023

Industry, Sector and Symbol

Industry
Commercial physical research
Sub-Industry
N/A
Sector
Medical
Current Symbol
NASDAQ:DKDCA
Web
N/A
Fax
N/A
Employees
2,021
Year Founded
N/A

Profitability

Net Income
$340,000.00
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A
Cash Flow
$0.07 per share
Book Value
($1.25) per share

Miscellaneous

Free Float
5,821,000
Market Cap
$81.76 million
Optionable
Not Optionable
Beta
0.02

Key Executives

  • Mr. Barry Anderson (Age 45)
    Chairman & CEO
  • Mr. Firdauz Edmin Bin Mokhtar (Age 49)
    CFO & Sec.













DKDCA Stock - Frequently Asked Questions

How have DKDCA shares performed in 2023?

Data Knights Acquisition's stock was trading at $10.44 at the beginning of the year. Since then, DKDCA stock has increased by 3.4% and is now trading at $10.80.
View the best growth stocks for 2023 here
.

Are investors shorting Data Knights Acquisition?

Data Knights Acquisition saw a increase in short interest in the month of May. As of May 15th, there was short interest totaling 3,900 shares, an increase of 8.3% from the April 30th total of 3,600 shares. Based on an average trading volume of 3,300 shares, the short-interest ratio is presently 1.2 days. Currently, 0.2% of the shares of the stock are sold short.
View Data Knights Acquisition's Short Interest
.

When is Data Knights Acquisition's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Monday, August 21st 2023.
View our DKDCA earnings forecast
.

What is Data Knights Acquisition's stock symbol?

Data Knights Acquisition trades on the NASDAQ under the ticker symbol "DKDCA."

Who are Data Knights Acquisition's major shareholders?

Data Knights Acquisition's stock is owned by a variety of retail and institutional investors. Top institutional shareholders include Shaolin Capital Management LLC (5.28%), Graham Capital Wealth Management LLC (2.44%), Atlas Merchant Capital LLC (1.72%), Wolverine Asset Management LLC (1.59%), Mizuho Securities USA LLC (1.32%) and SkyView Investment Advisors LLC (1.25%).

How do I buy shares of Data Knights Acquisition?

Shares of DKDCA stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Data Knights Acquisition's stock price today?

One share of DKDCA stock can currently be purchased for approximately $10.80.

How much money does Data Knights Acquisition make?

Data Knights Acquisition (NASDAQ:DKDCA) has a market capitalization of $81.76 million. The company earns $340,000.00 in net income (profit) each year or ($0.13) on an earnings per share basis.

How many employees does Data Knights Acquisition have?

The company employs 2,021 workers across the globe.

How can I contact Data Knights Acquisition?

The company can be reached via phone at 011-44-20-3833-4000.

This page (NASDAQ:DKDCA) was last updated on 6/4/2023 by MarketBeat.com Staff

My Account -